September 27 - 29, 2010, The Westin Hotel, St. Louis, Mo.
Invitation Only Event.
Complimentary Registration. Limited Seating.
CHESTERFIELD, Mo.--(BUSINESS WIRE)-- With orphan drug development accelerating at an increasing rate, evidenced by a 64 percent increase and the number of orphan drugs designated by the FDA between 2005 and 2009, Centric Health Resources, Inc. presents its Third Annual Ultra Orphan Conference: “Emerging Commercialization Strategies for Addressing the Needs of Ultra-Orphan Patients – Maximize Product Launch and Extend Product Life Cycle One Patient at a Time,” September 27-29, 2010, The Westin Hotel, St. Louis, Mo.
Conference participants, including biopharmaceutical companies, industry consultants, venture capital companies, patient advocacy groups, health plans, employers, and benefits managers will learn how the industry is rethinking, reorganizing, and restructuring.
“We are bringing together high profile industry thought leaders and key influencers who will present opportunities for creating a positive ROI out of a small marketplace and in an environment of health care reform, increasing regulatory requirements, and capital constraints,” says Craig Kephart, president and CEO of Centric, a nationwide, Patient-Centered Health Management® organization dedicated to improving the quality of life for people nationwide with rare, orphan, ultra-orphan, and chronic genetic disorders. “Since orphan drugs follow the same discovery process and timeline as larger drugs, and cost the same amount of money-- if not more-- it is important for attendees to learn about this vital marketplace and gain new insight into delivering these high-cost, low-volume drugs to patients who desperately need them.”
Centric works with patient advocacy organizations, pharmaceutical companies, biotech firms, and managed care organizations to deliver prescribed therapies and specialized health services.
Pharmaceutical Commerce Magazine is the lead media partner for the conference.
Kephart concludes, “This conference provides a forum for industry leaders to advance and elevate market focus on specialty and ultra-orphan drugs, which represent a new frontier in healthcare.”
Conference Registration Qualifications
This conference is provided exclusively for biopharmaceutical manufacturers, industry consultants, health plans, patient advocacy groups and venture capital firms. Attendance is by invitation only. Please go to http://www.centrichealthresources.com/2010Conference/ for more information on attending.
About Centric Health Resources
Centric Health Resources, Inc. is a nationwide, Patient-Centered Health Management® organization, serving patients with rare, ultra-orphan disorders. Biotech and pharmaceutical manufacturers maximize value by aligning with Centric for streamlined and flexible service offerings that include reimbursement expertise, delivery of specialty pharmaceuticals, peer health coaching, and clinical support from registered nurses. Centric connects physicians, nurses, health benefit payers, patient advocacy groups, biotech/pharmaceutical companies, and families together in partnership for improved service and health outcomes for these specialized patient populations. Visit www.CentricHealthResources.com http://www.centrichealthresources.com.
CPR Strategic Marketing Communications
Frani DePalo, 201-641-1911 x54
KEYWORDS: United States North America Missouri
INDUSTRY KEYWORDS: Practice Management Health Biotechnology Hospitals Pharmaceutical Other Health General Health Managed Care